ESPE Yearbook of Paediatric Endocrinology

Diabetes Care 2021;44:1898-1905. https://pubmed.ncbi.nlm.nih.gov/34285100/Brief Summary: This systematic review and meta-analysis of 46 studies and 6,468 participants (aged <20 years) provides evidence that youth with type 1 diabetes (T1D) have reduced lower body mineral density (BMD), as assessed by multiple modalities: DXA, peripheral quantitative computed tomography (pQCT), and/or qu...

To read the full abstract: J Clin Endocrinol Metab. 2020; 105(3): dgz255. PMID: 31825489.P450 oxidoreductase deficiency (PORD) is a rare autosomal recessive variant of congenital adrenal hyperplasia (CAH) arising from homozygous or compound heterozygous mutations to the gene encoding the enzyme P450 oxidoreductase (POR ) (1). Patients with PORD have a range of skeletal malformation...

Abstract: Lancet. 2019 May 16.In brief: In a randomised, active-controlled, open-label, phase 3 trial, burosumab (an anti-FGF23 antibody) demonstrated significantly greater clinical improvements in rickets severity, growth, and biochemistries among children with X-linked hypophosphataemia compared with continuation of conventional therapy with oral phosphate and active vitamin D ...